Search

Marc S Collett

from Bethesda, MD
Age ~74
Get Report
Also known as:
Marcs Collett, Marc S Roberts
Related to:
Ruby M RobertsCora Lee Roberts, 35Richard R Roberts, 87Leslie E Roberts, 74Nathan D Friedman, 35Robert M Friedman, 74Robert M Lindquist, 73
Connected to:
Alice S Collett, 45Alisha N Collett, 35Andrew M Collette, 45Anthony E Collett, 43April M Collett, 46Benedetta S Colletti, 57Betty I Collett, 70Blair Collette, 36Caitlin E Colletti, 32Calogero Colletta, 42

Marc Collett Phones & Addresses

  • Bethesda, MD
  • Lewes, DE
  • 4627 47Th St, Washington, DC 20016 (202) 537-1122 (202) 537-3390
  • 4200 Cathedral Ave, Washington, DC 20016 (202) 537-1122
  • 113 Juniper Ct, Collegeville, PA 19426 (610) 489-2235
  • 155 Gibbs St, Rockville, MD 20850 (301) 340-1135
  • Seattle, WA
  • Gaithersburg, MD
  • 113 Juniper Ct, Collegeville, PA 19426

Work

Position: Service Occupations

Education

Degree: High school graduate or higher

Publications

Amazon

Rift Valley Fever Virus: Molecular Biologic Studies of the M Segment RNA(Ribonucleic Acids) for Application in Disease Prevention

View page
Author

Marc S. Collett

Binding

Paperback

Publisher

PN

ISBN #

2

Flavivirus RNA Replication: Essential Viral Functions as Targets for Antiviral Therapeutics

View page
Author

Marc S. Collett

Binding

Paperback

Publisher

PN

ISBN #

1

Us Patents

Method For The Use Of Pyranoindole Derivatives To Treat Infection With Hepatitis C Virus

View page
US Patent:
7217730, May 15, 2007
Filed:
May 20, 2003
Appl. No.:
10/441984
Inventors:
Ariamala Gopalsamy - Mahwah NJ, US
John W. Ellingboe - Ridgewood NJ, US
Tarek S. Mansour - New City NY, US
Stephen M. Condon - Glenmoore PA, US
Matthew G. Laporte - Honey Brook PA, US
Christopher J. Burns - Malvern PA, US
Kaapjoo Park - Suffern NY, US
Marc S. Collett - Collegeville PA, US
Assignee:
Wyeth - Madison NJ
ViroPharma Incorporated - Exton PA
International Classification:
A61K 31/40
A61K 31/70
US Classification:
514411, 514 42, 514 43, 514894
Abstract:
The invention is directed to methods of treating, preventing, or inhibiting a Hepatitis C viral infection in a mammal comprising contacting the mammal with an effective amount of a compound of the formula:.

Methods For Identifying Inhibitors Of Helicase C Virus

View page
US Patent:
20020081574, Jun 27, 2002
Filed:
Dec 7, 2001
Appl. No.:
10/010860
Inventors:
Marc Collett - Collegeville PA, US
Daniel Pevear - Harleysville PA, US
James Groarke - Phoenixville PA, US
Dorothy Young - Collegeville PA, US
International Classification:
C12Q001/70
C12N009/22
C12N015/86
C12P021/02
US Classification:
435/005000, 435/069100, 435/199000, 435/456000
Abstract:
Assay methods are disclosed having utility in the identification of therapeutic agents effective against human hepatitis C virus and related viruses. NS3 protein derived from these viruses, representing a native and authentic version of the complete protein sequence, is used in the assay methods of the invention, which enables identification and development of anti-viral agents exhibiting inhibition of the protein's NTPase and RNA helicase activities.

Methods For Identifying Inhibitors Of Helicase Activity From Hepatitis C Virus

View page
US Patent:
20040076949, Apr 22, 2004
Filed:
Oct 10, 2003
Appl. No.:
10/684025
Inventors:
Marc Collett - Collegeville PA, US
Daniel Pevear - Harleysville PA, US
James Groarke - Phoenixville PA, US
Dorothy Young - Collegeville PA, US
International Classification:
C12Q001/70
C07H021/04
C12N009/22
C12N015/86
US Classification:
435/005000, 435/069100, 435/456000, 435/199000, 435/320100, 435/325000, 536/023200
Abstract:
Assay methods are disclosed having utility in the identification of therapeutic agents effective against human hepatitis C virus and related viruses. NS3 protein derived from these viruses, representing a native and authentic version of the complete protein sequence, is used in the assay methods of the invention, which enables identification and development of anti-viral agents exhibiting inhibition of the protein's NTPase and RNA helicase activities.

Methods Of Reducing Rhinovirus Contagion And Related Compositions

View page
US Patent:
20060167109, Jul 27, 2006
Filed:
Feb 14, 2003
Appl. No.:
10/504206
Inventors:
Daniel Pevear - Harleysville PA, US
Gerald Rhodes - Los Altos CA, US
Theodore Nitz - Pottstown PA, US
Mark McKinlay - Phoenixville PA, US
Marc Collett - Washington DC, US
International Classification:
A61K 31/137
US Classification:
514649000
Abstract:
The present invention relates to the use of pleconaril to reduce the contagion of rhinovirus virions shed from a host infected with a rhinovirus and thereby reduce disease transmission or re-infection.

Wikipedia

Mark Collett

View page

Mark Adrian Collett (born 3 October 1980) is a British political activist. He is a former chairman of the Young BNP, the youth division of the British National Party ...

Control profile
Marc S Collett from Bethesda, MD, age ~74 Get Report